KOLON LIFE SCIENCE Inc. Logo

KOLON LIFE SCIENCE Inc.

Develops cell/gene therapies and manufactures APIs and specialty chemicals.

102940 | KO

Overview

Corporate Details

ISIN(s):
KR7102940004
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡동로 110 코오롱 One&Only 타워, 서울특별시

Description

KOLON LIFE SCIENCE Inc. is a company operating through two primary business divisions: Bio and Chemical. The Bio division is a clinical-stage biotechnology unit focused on developing novel cell and gene therapies, with a pipeline that includes treatments for neuropathic pain and oncolytic virus therapies for cancer. The Chemical division develops, manufactures, and sells Active Pharmaceutical Ingredients (APIs), specialty chemicals, antimicrobials, and water treatment solutions. The company leverages its expertise in both biotechnology and chemical manufacturing to provide advanced healthcare and environmental products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-09-10 00:00
기타주요경영사항(인보사케이주 K&L Grade 2 임상3상에 대한 임상시험계획승인 취소 명령 효력정지 신청 기각)
Korean 5.3 KB
2019-09-02 00:00
소송등의제기ㆍ신청(일정금액이상의청구)
Korean 7.1 KB
2019-09-02 00:00
불성실공시법인지정예고(공시불이행)
Korean 5.2 KB
2019-08-30 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 58.6 KB
2019-08-29 00:00
대규모기업집단현황공시[분기별공시(대표회사용)]
Korean 77.8 KB
2019-08-19 00:00
불성실공시법인지정(공시번복)
Korean 6.9 KB
2019-08-19 00:00
기타경영사항(자율공시)('인보사케이주' 제조판매 품목허가 취소처분 효력정지 신청 기각결정에 대한 즉시 항고장 제출)
Korean 7.6 KB
2019-08-14 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 13.7 KB
2019-08-14 00:00
반기보고서 (2019.06)
Korean 1.2 MB
2019-08-13 00:00
기타주요경영사항('인보사케이주' 제조판매 품목허가 취소처분 (2019.7.9일자) 효력정지 신청 기각)
Korean 5.6 KB
2019-07-26 00:00
기타주요경영사항(인보사케이주 의약품 회수·폐기 명령 집행 정지)
Korean 5.2 KB
2019-07-25 00:00
소송등의제기ㆍ신청(일정금액이상의청구)
Korean 7.8 KB
2019-07-24 00:00
단일판매ㆍ공급계약해지
Korean 8.5 KB
2019-07-24 00:00
불성실공시법인지정예고(공시번복)
Korean 5.2 KB
2019-07-09 00:00
기타경영사항(자율공시)(식품의약품안전처의 행정처분에 대한 행정소송 및 효력정지신청서 제출)
Korean 16.9 KB

Automate Your Workflow. Get a real-time feed of all KOLON LIFE SCIENCE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOLON LIFE SCIENCE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOLON LIFE SCIENCE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.